Q. Any changes in fraction bioavailable, elimination half-life indicates nonlinearity of that particular drug.

View solution

Q. Which of the following creates nonlinearity in drug distribution and not in drug absorption?

View solution

Q. Which one of these are correct Michaelis-Menten equation?

View solution

Q. What is bioavailability?

View solution

Q. What is the equation of bioavailable fraction?

View solution

Q. Which of the following is not an objective of bioavailability studies?

View solution

Q. Single-dose bioavailability studies are simple and common.

View solution

Q. Multiple dose study is better since we can understand the peak, valley, drug blood levels, etc.

View solution

Q. Which of the following is the pharmacodynamics method of studying bioavailability?

View solution

Q. Which of the following is not an important parameter of plasma level time studies?

View solution

Q. What is the equation for bioavailability?

View solution

Q. The urinary excretion of the unchanged drug is directly proportional to the plasma concentration of a drug.

View solution

Q. Which of the following will not be a parameter that should be examined for urinary excretion data?

View solution

Q. Which of the following is not measured in acute pharmacological response study?

View solution

Q. Therapeutic response is based on observing the clinical response to a drug formulation.

View solution

Q. In vitro determination of bioavailability by dissolution rate is not the best way to determine therapeutic efficacy.

View solution

Q. What is bioequivalence?

View solution

Q. What is the chemical equivalence?

View solution

Q. What is pharmaceutic equivalence?

View solution

Q. What is bioequivalence?

View solution